product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Hic-5 Antibody
catalog :
4914
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, cow
application :
western blot, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 4
Reference
Aghajanian H, Cho Y, Manderfield L, Herling M, Gupta M, Ho V, et al. Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. Nat Commun. 2016;7:12038 pubmed publisher
Kim I, He Y. Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy. Front Oncol. 2013;3:175 pubmed publisher
Ryan P, Kales S, Yadavalli R, Nau M, Zhang H, Lipkowitz S. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5. PLoS ONE. 2012;7:e49428 pubmed publisher
Pleschka S, Stein M, Schoop R, Hudson J. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:197 pubmed publisher
product information
SKU :
4914S
Product-Name :
Hic-5 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk, B
Applications :
Immunoprecipitation
Product-Category :
Adhesion/ECM
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
50
Host :
Rabbit
Target :
Hic-5
Primary-Protein :
Hic-5
Alt-Names :
ARA55,Androgen receptor coactivator 55 kDa protein,Androgen receptor-associated protein of 55 kDa,HIC5,Hic-5,Hydrogen peroxide-inducible clone 5 protein,TGFB1I1,TGFI1,TSC-5,Transforming growth factor beta-1-induced transcript 1 protein,androgen receptor coactivator ARA55,transforming growth factor beta 1 induced transcript 1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.